Judge won't allow AFT Pharmaceuticals to submit more evidence in Pascomer dispute
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
On the Money: The Parises, The Chrises, The New Year, and more
The business and political year has kicked into gear, and so has On the Money.
Five reasons gold is surging toward US$5,000 an ounce
Buying the precious metal has become the antidote for market jitters.
Generative AI will disrupt 90% of jobs - what it means for the future of work
Here’s what that means for the future of work in New Zealand.
AI is only as good as its data foundation
NZ leaders explain why clean, connected data drives AI value.
